cyc 202 has been researched along with silybin in 2 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (silybin) | Trials (silybin) | Recent Studies (post-2010) (silybin) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 49 | 0 | 25 |
| 979 | 7 | 393 | 1,133 | 31 | 816 |
| Protein | Taxonomy | cyc 202 (IC50) | silybin (IC50) |
|---|---|---|---|
| Polyphenol oxidase 2 | Agaricus bisporus | 1.7 | |
| Trypsin-1 | Homo sapiens (human) | 3.7 | |
| Trypsin-2 | Homo sapiens (human) | 3.7 | |
| Trypsin-3 | Homo sapiens (human) | 3.7 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 4.2658 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 6.1659 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Reincke, M; Theodoropoulou, M | 1 |
1 review(s) available for cyc 202 and silybin
| Article | Year |
|---|---|
Tumor-Directed Therapeutic Targets in Cushing Disease.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Antineoplastic Agents; Cabergoline; Clinical Trials as Topic; Corticotrophs; Humans; Pituitary ACTH Hypersecretion; Roscovitine; Silybin; Somatostatin; Treatment Outcome; Tretinoin | 2019 |
1 other study(ies) available for cyc 202 and silybin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |